COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,669 Articles (22,913 medRxiv, 8,756 bioRxiv)

Most recent first Previous |  Page 1439: Articles 14381-14390  | Next

Epidemiological dynamics of SARS-CoV-2 VOC Gamma in Rio de Janeiro, Brazil
Moreira, F. R. R., D'arc, M., Mariani, D., Herlinger, A. L., Schiffler, F. B., Rossi, A. D., Leitao, I. d. C., Miranda, T. d. S., Cosentino, M. A. C., Torres, M. C. d. P., da Costa, R. M. d. S. C., Goncalves, C. C. A., Faffe, D. S., Galiez, R. d. M., Ferreira, O. C., Aguiar, R. S., Santos, A. F. A. d., Voloch, C. M., Castineiras, T. M. P. P., Tanuri, A., COVID-19-UFRJ Workgroup
10.1101/2021.07.01.21259404 — Posted: 2021-07-06
The Ultra Fit Community Mask - Toward Maximal Respiratory Protection via Personalized Face Fit
Hyun, C., Jensen, M. M., Yang, K., Weaver, J. C., Wang, X., Kudo, Y., Gordon, S. J., Karp, J. M., Samir, A. E.
10.1101/2021.07.01.21259428 — Posted: 2021-07-06
Indirect impact on number of admitted children with COVID-19 in the first three months of emergency use of two vaccines, in Rio de Janeiro, Brazil
Fonseca, C. G. B., Costa, A. L. T. G., Esteves, M. D. M., de Carvalho, B. R. R., Souza, C. V., Teixeira, C. H., Araujo da Silva, A. R.
10.1101/2021.07.01.21259330 — Posted: 2021-07-06
Prevalence of Long COVID symptoms in Bangladesh: A Prospective Inception Cohort Study of COVID-19 survivors.
Hossain, M. A., Hossain, K. M. A., Saunders, K., Uddin, Z., Walton, L. M., Raigangar, V., Sakel, M., Shafin, R., Hossain, M. S., Kabir, M. F., Faruqui, R., Rana, S., Ahmed, M. S., Chakrovorty, S. K., Hossain, M. A., Jahid, I. K.
10.1101/2021.07.03.21259626 — Posted: 2021-07-06
Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 mRNA
Tenbusch, M., Schumacher, S., Vogel, E., Priller, A., Held, J., Steininger, P., Beileke, S., Irrgang, P., Brockhoff, R., Salmanton-Garcia, J., Tinnefeld, K., Mijocevic, H., Schober, K., Bogdan, C., Yazici, S., Knolle, P., Cornely, O. A., Ueberla, K., Protzer, U.
10.1101/2021.07.03.21258887 — Posted: 2021-07-06
Generation of false positive SARS-CoV-2 antigen results with testing conditions outside manufacturer recommendations: A scientific approach to pandemic misinformation
Patriquin, G., Davidson, R., Hatchette, T. F., Heade, B. M., Mejia, E., Becker, M. G., Meyers, A. F. A., Sandstrom, P. A., Hatchette, J., Block, A., Smith, N., Ross, J., LeBlanc, J. J.
10.1101/2021.07.04.21259490 — Posted: 2021-07-06
Mathematical modelling of SARS-CoV-2 variant outbreaks reveals their probability of extinction
Schioler, H., Knudsen, T., Brondum, R. F., Stoustrup, J., Bogsted, M.
10.1101/2021.07.05.21260005 — Posted: 2021-07-06
COVID-19 and regional differences in the timeliness of hip-fracture surgery: an interrupted time-series analysis
Golinelli, D., Lenzi, J., Adorno, E., Gianino, M. M., Fantini, M. P.
10.1101/2021.07.02.21259910 — Posted: 2021-07-06
Implementation, adoption and perceptions of telemental health during the COVID-19 pandemic: a systematic review
Appleton, R., Williams, J., Vera San Juan, N., Needle, J., Schlief, M., Jordan, H., Sheridan Rains, L., Goulding, L., Badhan, M., Roxburgh, E., Barnett, P., Spyridonidis, S., Tomaskova, M., Mo, J., Harju-Seppanen, J., Haime, Z., Casetta, C., Papamichail, A., Lloyd-Evans, B., Simpson, A., Sevdalis, N., Gaughran, F., Johnson, S.
10.1101/2021.07.05.21260018 — Posted: 2021-07-06
The impact of demographic factors on the accumulated number of COVID-19 cases per capita in Europe and the regions of Ukraine in the summer of 2021
Nesteruk, I., Rodionov, O.
10.1101/2021.07.04.21259980 — Posted: 2021-07-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).